Search Results
10
Everything
Search Filters
Organization
PharmAla Biotech
PharmAla Contracts with Partner to Act as US Distributor
March 24, 2025 09:00 ET
|
PharmAla Biotech
PharmAla sidesteps tariff risk and expands clinical operations in the United States by contracting with Sharp Clinical Services as distribution partner
PharmAla Completes Shipment of LaNeo™ MDMA to the University of Washington
March 21, 2025 09:00 ET
|
PharmAla Biotech
PharmAla completes shipment of MDMA to University of Washington, to be used in a Narcissism clinical trial. It also appoints Ali Taghva as CCO.
PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands
March 10, 2025 09:24 ET
|
PharmAla Biotech
PharmAla opens the European Market for MDMA, signs Duchefa Farma as its first national-level distributor for LaNeo MDMA in Europe
PharmAla Completes Shipment of LaNeo™ MDMA to UCLA for Schizophrenia Study
March 03, 2025 09:01 ET
|
PharmAla Biotech
PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA
February 27, 2025 14:45 ET
|
PharmAla Biotech
PharmAla to supply the STRONG STAR Consortium with new 20mg MDMA dose to treat active-duty military personnel in a clinical trial
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
February 06, 2025 16:06 ET
|
PharmAla Biotech
PharmAla adds Matthew Azrieli to Advisory Team
PharmAla Issues Q1 Financial Statements
January 29, 2025 16:10 ET
|
PharmAla Biotech
PharmAla releases its Q1 financial statements
PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel
January 20, 2025 08:55 ET
|
PharmAla Biotech
PharmAla partners with Merhavim and MAPS Israel for innovative MDMA PTSD clinical trial data sharing partnership in wake of Gaza Ceasefire
PharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private Placement
December 20, 2024 16:55 ET
|
PharmAla Biotech
PharmAla files audited financials for year ended August 31, 2024, completes continuance and oversubscribed private placement
PharmAla Announces Private Placement
December 13, 2024 09:25 ET
|
PharmAla Biotech
PharmAla announces private placement financing